Skip to main content
FinSpry Logo
FinSpry
CSTL logo
CSTL
(NASDAQ)
Castle Biosciences, Inc.
$24.84-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Castle Biosciences (CSTL) Stock Price & Financial Analysis

Castle Biosciences Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$24.09 - $25.22
52-Week High$44.28
52-Week Low$14.59
Open$24.41
Volume288.51K
Average Volume (3M)288.51K
Market Cap720.01M
Shares Outstanding28.99M
Price to Sales (P/S)2.11
Price to Book (P/B)1.54
EV/EBITDA56.98
Revenue (TTM)344.23M
Net Income (TTM)-24.16M
Free Cash Flow (TTM)28.33M
EPS (TTM)$-0.82
Profit Margin-7.02%
Operating Margin-12.44%
Return on Equity (ROE)-5.13%
Debt to Equity0.08
50-Day MA$30.88
200-Day MA$27.90
52-Week Change26.64%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Castle Biosciences

What is the current stock price for CSTL?

As of the latest trading session, CSTL stock trades at $24.84. The 52-week range is $14.59–$44.28, with a day range of $24.09–$25.22.

What is the P/E ratio for CSTL?

The P/E ratio (Price-to-Earnings) for CSTL is shown in the Key Statistics section. This valuation metric helps compare Castle Biosciences, Inc. to industry peers.

Does CSTL pay dividends?

Castle Biosciences does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CSTL?

Based on 3 analysts, the consensus for CSTL is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of CSTL?

Castle Biosciences's market capitalization is $720.0M, classifying it as a small-cap company. Castle Biosciences operates in the Healthcare sector within the Diagnostics & Research industry.